Start Your Pharmacovigilance Career Today | Episode 1 Full Foundation Class

Introduction to Pharmacovigilance

Overview of the Channel and Course

• The speaker, Siddhesh, introduces himself and his channel "Siddu Speaks," where he previously created informational videos. He now aims to teach pharmacovigilance through a structured course on YouTube.

• The intention behind starting these classes is to provide comprehensive knowledge about pharmacovigilance from scratch to advanced levels, divided into episodes uploaded daily.

Importance of Conceptual Understanding

• Siddhesh emphasizes that many students learn without grasping the core concepts, often relying on presentations without understanding their significance. This lack of clarity can hinder performance in interviews where conceptual questions are asked.

• He stresses that having a complete understanding of concepts is crucial for framing answers effectively during interviews and practical applications in the field.

Course Structure and Learning Approach

Daily Video Uploads

• Each video will last between 30 to 40 minutes, focusing on different aspects of pharmacovigilance, encouraging viewers to watch completely and share with friends for collective learning.

Bilingual Teaching Methodology

• The speaker plans to explain concepts primarily in Telugu while also incorporating English explanations since interview questions are typically posed in English. This dual-language approach aims to enhance comprehension among learners who may struggle with English alone.

Pharmacovigilance Episode One: What is Pharmacovigilance?

Key Topics Covered

• The first episode addresses fundamental questions such as what pharmacovigilance is, its importance, foundational history, and key stakeholders involved in the field. It sets the stage for deeper exploration into drug safety monitoring practices.

Drug Life Cycle Discussion

• A significant focus will be on understanding the drug life cycle from laboratory development through patient administration, highlighting how pharmacovigilance fits within this process as an ongoing concern throughout a drug's lifecycle.

Understanding Adverse Effects and Reporting

Definition of Pharmacovigilance

• Pharmacovigilance is defined as a science related to detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems; it encompasses more than just collecting side effect reports but involves comprehensive analysis and prevention strategies as well.

Importance of Monitoring Drug Safety

• Every medication has potential risks associated with its use; thus monitoring adverse effects becomes essential for public health protection by ensuring that harmful impacts are identified early through systematic observation and reporting mechanisms established by professionals in the field.

Clinical Trials vs Post-Marketing Surveillance

Limitations of Clinical Trials

• Clinical trials have inherent limitations due to small sample sizes which may not capture rare side effects that could emerge once drugs are used by larger populations post-marketing; hence continuous monitoring after approval is critical for identifying unforeseen issues with medications once they reach consumers at scale.

Role of Regulatory Authorities

• Regulatory authorities play a vital role in approving drugs based on clinical trial data but must remain vigilant post-market release as real-world usage can reveal additional safety concerns not evident during initial testing phases; this ongoing vigilance underscores the necessity for robust pharmacovigilance systems globally.

Understanding Drug Safety and Clinical Trials

Limitations of Clinical Trials

• Over 3 million people began using a drug before receiving approval, leading to potential side effects in a small sample size of 10,000 individuals.

• The duration of clinical trials is often limited to months or a few years, while some side effects may only appear after many years of use, known as delayed effects.

• Rare side effects are difficult to detect in clinical trials due to their limited duration and the selected population involved in these studies.

Population Selection in Trials

• Healthy volunteers and specific patient populations are chosen for trials; pregnant women, elderly patients, children, and those with multiple diseases are typically excluded.

• In real life, once drugs are released into the market, they are used by diverse populations that were not included in clinical trials.

Real-Life Drug Use vs. Controlled Conditions

• The safety profile of a drug can differ significantly when used by the general public compared to controlled conditions during trials where dosages and other medications are closely monitored.

• Patients often take multiple medications simultaneously and may miss doses or alter dosages based on various factors.

Benefit-Risk Balance

• The concept of benefit-risk balance is crucial; it involves weighing the benefits against potential risks associated with drug use.

• No drug can be deemed 100% safe; all drugs have the potential to cause harm under certain conditions or dosages.

Decision-Making in Drug Use

• Decisions about which drugs to use involve assessing whether the benefits outweigh the risks for specific patient populations at specific dosages.

• A simple question guides this assessment: Do the benefits of this drug outweigh its risks?

Examples Illustrating Benefit-Risk Assessment

Paracetamol Case Study

• Paracetamol effectively relieves fever and pain at normal doses but poses risks such as liver damage if taken excessively.

Cancer Chemotherapy Insights

• Chemotherapy can kill cancer cells and extend life but carries severe side effects like nausea and immune system damage.

• For aggressive cancers where death is imminent without treatment, these severe side effects may be considered acceptable.

Warfarin Usage Analysis

• Warfarin prevents blood clots but increases bleeding risk; thus its use must be carefully evaluated based on individual stroke risk versus bleeding risk.

Historical Context of Pharmacovigilance

Tragedies Leading to Regulatory Changes

Sulfanilamide Incident (1937)

• The sulfanilamide elixir disaster led to over 100 deaths due to kidney failure from toxic ingredients used without proper safety testing.

Thalidomide Disaster (1947 - 1962)

• Thalidomide was marketed as a sedative but caused severe birth defects when taken by pregnant women. This incident highlighted the need for rigorous testing on unborn babies.

Vioxx Withdrawal (2004)

• Vioxx was withdrawn after studies revealed increased heart attack and stroke risks among users compared to those taking placebo.

These historical events underscore the importance of stringent safety regulations for pharmaceuticals before they reach consumers.

Understanding Regulatory Authorities in Drug Safety

Role of Regulatory Authorities

• Every country has regulatory authorities responsible for approving drugs and monitoring their safety. These bodies ensure that new medicines are either approved or monitored for safety.

• The FDA (Food and Drug Administration) is the regulatory authority in the United States, while the EMA (European Medicines Agency) serves the European Union. In India, this role is fulfilled by the CDSCO (Central Drugs Standard Control Organization).

• Other notable organizations include the MHRA (Medicines and Healthcare products Regulatory Agency) in the UK and WHO (World Health Organization), which coordinates global health efforts.

Importance of Healthcare Professionals

• Healthcare professionals such as doctors, nurses, and dentists play a crucial role on the front lines of patient care. They observe patients taking medications and report any adverse events.

• Reports from healthcare professionals are vital; they can report directly to companies or regulatory authorities through pharmacovigilance programs like India's portal for spontaneous reports.

Spontaneous Reporting System

• Spontaneous reports from healthcare professionals are one of the most important sources of safety information within pharmacovigilance systems.

• These reports help identify adverse effects experienced by patients after taking medications, contributing significantly to drug safety monitoring.

Patient Reporting Systems

• Many regulators have established patient reporting systems because patient experiences provide valuable insights that clinical data may not capture fully.

• When patients report their experiences with medications, it adds a layer of security to drug safety assessments.

Uppsala Monitoring Centre

• The Uppsala Monitoring Centre in Sweden operates on behalf of WHO and manages VigiBase, which contains over 40 million individual case safety reports from more than 130 countries.

• This center communicates detected signals to member countries and WHO for further evaluation, playing a critical role in global drug safety monitoring.

Contract Research Organizations (CROs)

Functionality of CROs

• CROs provide outsourced services to pharmaceutical companies instead of building entire in-house teams. They handle various aspects including pharmacovigilance operations.

• Marketing authorization holders often rely on CRO services to manage their pharmacovigilance needs effectively.

Opportunities within CRO Sector

• Many fresh graduates find opportunities within CRO environments as drug safety associates due to high demand for skilled personnel in this field.

Qualified Person for Pharmacovigilance (QP)

Role Definition

• A QP is a senior professional legally required under European law for every pharmaceutical company operating within the EU. They hold personal accountability for the entire pharmacovigilance system.

Responsibilities

• If any issues arise regarding safety reports or if signals are ignored, the QP is personally responsible before regulatory authorities.

Career Growth in Pharmacovigilance

Pathways Available

• Careers in pharmacovigilance offer structured growth opportunities starting from roles like Drug Safety Associate up to prestigious positions such as QP.

Meaningful Work Impact

• Each case processed contributes meaningfully towards protecting real patients worldwide by identifying potential harm caused by medications.

Conclusion: The Significance of Pharmacovigilance

Summary Insights

• Pharmacovigilance plays an essential role globally due to legal requirements across all countries ensuring drug safety through systematic processes involving various stakeholders including regulatory authorities, healthcare professionals, patients, CRO’s ,and qualified persons.